Paasa Logo
Medpace Holdings, Inc. logo
MEDPNASDAQMarket closedOpens 9:30am ET

Medpace Holdings, Inc.

$618.88Last updated
-$1.71 (0.28%)Past day
Timezone

Medpace Holdings, Inc. (NASDAQ: MEDP) is trading at $618.88, about ₹59,363 at today's USD/INR rate, as of 25 Sep 2026, 4:00 PM ET, down 0.28% today. Indian residents can buy Medpace from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$620.60
Previous close:$620.59
Volume:229.01K

Today's low

$608.11

Today's high

$620.60

52 week low

$373.00

52 week high

$677.90

MEDP opened at $620.60, closed previously at $620.59, and has traded between $373.00 and $677.90 over the past 52 weeks.

About

Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.

Country
US
CEO
August James Troendle
Exchange listed on
NASDAQ
Industry
Medical - Diagnostics & Research
Base currency
USD
Full Time Employees
6,500
Sector
Healthcare
IPO date
11/08/2016

Key statistics

Avg. volume

289.61K

Market cap

$17.27B

P/E Ratio

35.59

Price-to-sales ratio

6.21

Enterprise value

$16.89B

Free cash flow yield

4.25%

Debt-to-equity ratio

0.28

Return on equity

110.15%

ROIC

77.00%

Beta

1.15

Dividend yield

0.00%

Last dividend

$0.00

Financial overview

Revenue

$2.53B

Earnings per share

$15.64

Free cash flow

$681.87M

Net profit margin

17.67%

Gross margin

28.76%

EBITDA

$570.50M

Revenue growth

19.97%

Similar securities

This is not an investment recommendation

How to buy Medpace from India

Indian residents can buy Medpace shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for Medpace and place an order

    Find Medpace by name or by its ticker, MEDP, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Medpace trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Medpace position in USD and INR. Medpace pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in Medpace from India

Trading and taxes when buying Medpace from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneMedpace does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
US estate tax
May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy Medpace stock?

Yes. Medpace (MEDP) has been listed on NASDAQ since 2016, in the Medical - Diagnostics & Research industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one Medpace share cost in rupees?

One Medpace share is $618.88 — about ₹59,363 at a USD/INR rate of 95.92 on 25 Sep 2026. Both the Medpace price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Medpace from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy Medpace with less than the price of one share?

Yes. A whole Medpace share is $618.88, but there is no minimum trade size: you enter a rupee or dollar amount and receive the matching fraction.

How are gains on Medpace shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Medpace price. Paasa issues a capital-gains statement for your return.

Does Medpace pay a dividend?

No. Medpace does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Medpace from India?

NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is there estate or inheritance tax on Medpace shares held from India?

US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.

Do I have to declare Medpace shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Medpace holding, its cost and its closing value.

How do I sell Medpace and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.